Point of Care Rapid Diagnostics Market – Trends Forecast Till 2028

Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-HC-RDM-407

Format:  

Number of Pages: 338

Domain: Healthcare

Point of Care/Rapid Diagnostics Market – Trends Forecast Till 2028

The global point of care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4% during the forecast period

Point of care testing refers to medical diagnostic testing that is known to be conducted in ad around the point of care. It allows medical practitioners to achieve precise, lab-quality and diagnostic results in real-time within minutes.

Technological advancements in POC devices, increasing incidence of infectious diseases, and rapid growth in investments by key players are some of the factors that are driving the Market.

The COVID-19 pandemic has significantly affected the point of care diagnostics market. The outbreak of COVID-19 has expedited the global demand for diagnostic kits to rapidly detect thedisease. However, countries across the globe are facing a severe shortage of laboratory-based molecular assays. Thus, many players are emphasizing on increasing the supply of tests worldwide.

Rapid Diagnostics Market Analysis

North America (comprising the US and Canada) dominates point of care diagnostics market. North America is a gaining traction with the increasing incidence and prevalence of lifestyle diseases. Moreoer resence of major key platers in the region, facourable government scenarios, higher awarness of self tetsing and home care products and significant adoption of novel technologies are likely to play a major role in fueling the growth of the point of care diagnostics market in the North America.

Point of Care/Rapid Diagnostics Marketis segmented into platform, product, mode of purchase, end user and region.

On the basis of Product

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Pregnancy & Fertility Testing Products
  • Fecal Occult Testing Products
  • Hematology Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Drugs-of-abuse Testing Products
  • Cholesterol Testing Products
  • Other POC Products

On the basis of Platform

  • Lateral Flow Assays
  • Immunoassays
  • Microfluidics 1
  • Molecular Diagnostics
  • Dipsticks

On the basis of Mode of Purchase

  • OTC Testing Products
  • Prescription-based Testing Products

On the basis of End-Users

  • Outpatient & Ambulatory Care Facilities
  • Hospitals & Critical Care Centres
  • Home Care Settings 5
  • Other End Users

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Rapid Diagnostics Market Market Respondents

 

Key Players

  • Roche diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Becton,
  • Dickinson and Company
  •  Johnson & Johnson
  • Danaher Corporation
  • Chembio Diagnostics
  • Quidel Corporation
  • EKF Diagnostics
  • Trinity Biotech
  • AccuBioTech
  • Nova Biomedical
  • PTS Diagnostics
  • Instrumentation Laboratory Company
  • Sekisui Diagnostics

Recent Developments

  • In 2019, Roche Diagnostics FDA approval for the VENTANA PD-L1 (SP142) Assay for identifying triple-negative breast cancer (TNBC) patients.
  • In 2019, Abott announced the launch of Affinion HbA1c Dx Assay , a point of care test for diabetes.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Point of Care/Rapid Diagnostics Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 7.1 billion

Growth Rate

CAGR of 10.0% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

material type, end use, implementation and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

  • Roche diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Becton,
  • Dickinson and Company
  •  Johnson & Johnson
  • Danaher Corporation
  • Chembio Diagnostics
  • Quidel Corporation
  • EKF Diagnostics
  • Trinity Biotech
  • AccuBioTech
  • Nova Biomedical
  • PTS Diagnostics
  • Instrumentation Laboratory Company
  • Sekisui Diagnostics

Available Customization

In addition to the market data for Point of Care/Rapid Diagnostics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.